Targeted limbic self-neuromodulation for alleviating central sensitization symptoms in fibromyalgia.
Or-Borichev A, Lerner Y, Hamrani Y, Gurevitch G, Mor N, Doron M, Sarna N, Ablin JN, Hendler T, Sharon H.
Or-Borichev A, et al.
BMC Med. 2025 May 28;23(1):304. doi: 10.1186/s12916-025-04138-3.
BMC Med. 2025.
PMID: 40437546
Free PMC article.
Clinical Trial.
Disease severity and symptom burden were assessed using the Symptom Severity Score (SSS), along with other questionnaires administered before and after treatment. A clinical follow-up was performed 10-12 months post-intervention. RESULTS: NFT led to a significant immediate …
Disease severity and symptom burden were assessed using the Symptom Severity Score (SSS), along with other questionnaires administered befor …